HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity

被引:763
作者
Zhang, Huafeng
Gao, Ping
Fukuda, Ryo
Kumar, Ganesh
Krishnamachary, Balaji
Zeller, Karen I.
Dang, Chi V.
Semenza, Gregg L. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Vasc Biol Program, Inst Cell Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA
[7] Univ Chicago, Dept Med, Ctr Syst Biol, Chicago, IL 60637 USA
关键词
D O I
10.1016/j.ccr.2007.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many cancer cells are characterized by increased glycolysis and decreased respiration, even under aerobic conditions. The molecular mechanisms underlying this metabolic reprogramming are unclear. Here we show that hypoxia-inducible factor 1 (HIF-1) negatively regulates mitochondrial biogenesis and O-2 consumption in renal carcinoma cells lacking the von Hippel-Lindau tumor suppressor (VHL). HIF-1 mediates these effects by inhibiting C-MYC activity via two mechanisms. First, HIF-1 binds to and activates transcription of the MXI1 gene, which encodes a repressor of C-MYC transcriptional activity. Second, HIF-1 promotes MXI-1-independent, proteasome-dependent degradation of C-MYC. We demonstrate that transcription of the gene encoding the coactivator PGC-1 beta is C-MYC dependent and that loss of PGC-1 beta expression is a major factor contributing to reduced respiration in VHL-deficient renal carcinoma cells.
引用
收藏
页码:407 / 420
页数:14
相关论文
共 67 条
[31]  
MANDRIOTA SJ, 2002, CANCER CELL, V1, P59
[32]   The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma [J].
Maranchie, JK ;
Vasselli, JR ;
Riss, J ;
Bonifacino, JS ;
Linehan, WM ;
Klausner, RD .
CANCER CELL, 2002, 1 (03) :247-255
[33]   p53 regulates mitochondrial respiration [J].
Matoba, Satoaki ;
Kang, Ju-Gyeong ;
Patino, Willmar D. ;
Wragg, Andrew ;
Boehm, Manfred ;
Gavrilova, Oksana ;
Hurley, Paula J. ;
Bunz, Fred ;
Hwang, Paul M. .
SCIENCE, 2006, 312 (5780) :1650-1653
[34]   The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis [J].
Maxwell, PH ;
Wiesener, MS ;
Chang, GW ;
Clifford, SC ;
Vaux, EC ;
Cockman, ME ;
Wykoff, CC ;
Pugh, CW ;
Maher, ER ;
Ratcliffe, PJ .
NATURE, 1999, 399 (6733) :271-275
[35]   Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma [J].
Meierhofer, D ;
Mayr, JA ;
Foetschl, U ;
Berger, A ;
Fink, K ;
Schmeller, N ;
Hacker, GW ;
Hauser-Kronberger, C ;
Kofler, B ;
Sperl, W .
CARCINOGENESIS, 2004, 25 (06) :1005-1010
[36]   Inhibiting hypoxia-inducible factor 1 for cancer therapy [J].
Melillo, Giovanni .
MOLECULAR CANCER RESEARCH, 2006, 4 (09) :601-605
[37]   Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity [J].
Moeller, BJ ;
Dreher, MR ;
Rabbani, ZN ;
Schroeder, T ;
Cao, YT ;
Li, CY ;
Dewhirst, MW .
CANCER CELL, 2005, 8 (02) :99-110
[38]   Prognostic factors for survival of patients with stage IV renal cell carcinoma: Memorial Sloan-Kettering Cancer Center experience [J].
Motzer, RJ ;
Bacik, J ;
Mazumdar, M .
CLINICAL CANCER RESEARCH, 2004, 10 (18) :6302S-6303S
[39]   Functional analysis of the N-terminal domain of the Myc oncoprotein [J].
Oster, SK ;
Mao, DYL ;
Kennedy, J ;
Penn, LZ .
ONCOGENE, 2003, 22 (13) :1998-2010
[40]   Accelerated publication -: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc [J].
Osthus, RC ;
Shim, H ;
Kim, S ;
Li, Q ;
Reddy, R ;
Mukherjee, M ;
Xu, Y ;
Wonsey, D ;
Lee, LA ;
Dang, CV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) :21797-21800